Andrea Modrego
Overview
Explore the profile of Andrea Modrego including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Campos-Mata L, Trinite B, Modrego A, Tejedor Vaquero S, Pradenas E, Pons-Grifols A, et al.
Nat Commun
. 2024 Feb;
15(1):1051.
PMID: 38316751
Here we report the characterization of 17T2, a SARS-CoV-2 pan-neutralizing human monoclonal antibody isolated from a COVID-19 convalescent individual infected during the first pandemic wave. 17T2 is a class 1...
2.
Modrego A, Carlero D, Arranz R, Martin-Benito J
Viruses
. 2023 Mar;
15(3).
PMID: 36992363
Single-stranded RNA viruses (ssRNAv) are characterized by their biological diversity and great adaptability to different hosts; traits which make them a major threat to human health due to their potential...
3.
Garcia-Carbonero R, Anton-Pascual B, Modrego A, Del Carmen Riesco-Martinez M, Lens-Pardo A, Carretero-Puche C, et al.
Endocr Rev
. 2023 Mar;
44(4):724-736.
PMID: 36879384
Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas are aggressive neoplasms of challenging clinical management. A small proportion of patients with early-stage disease may achieve long-term survival, but the majority of patients present...
4.
Riesco-Martinez M, Modrego A, Espinosa-Olarte P, La Salvia A, Garcia-Carbonero R
Curr Treat Options Oncol
. 2022 Aug;
23(9):1320-1337.
PMID: 35980520
Colorectal cancer (CRC) is a major public health problem and the 2nd leading-cause of cancer-related death worldwide. Around 30% of patients present with metastatic disease and 50% of those with...
5.
Modrego A, Amaranto M, Godino A, Mendoza R, Barra J, Corchero J
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34204583
Fabry disease (FD) is a lysosomal storage disease caused by mutations in the gene for the α-galactosidase A (GLA) enzyme. The absence of the enzyme or its activity results in...
6.
Baena J, Modrego A, Zeaiter A, Kahatt C, Alfaro V, Jimenez-Aguilar E, et al.
Future Oncol
. 2021 Mar;
17(18):2279-2289.
PMID: 33736462
Lurbinectedin is a marine-derived drug that inhibits transcription, a process that is frequently dysregulated in small cell lung cancer. The activity of lurbinectedin has been studied in many solid tumors,...